Seongkon Kim

Statistics

Publications

Citations

951

H-Index

Active since

1990

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Karo Pharma (Sweden)

Purdue University West Lafayette

United States Military Academy

Seongkon Kim is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and organic chemistry.

Publications per year

1990–2014

Publications

Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®

Timothy A. Blizzard, Helen Chen, Seongkon Kim et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 161 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators

Seongkon Kim, Jane Y. Wu, Elizabeth T. Birzin et al. · Journal of Medicinal Chemistry · 2004 · 101 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Biomimetic Total Syntheses of (+)-Cephalostatin 7, (+)-Cephalostatin 12, and (+)-Ritterazine K

Jae Uk Jeong, Scott C. Sutton, Seongkon Kim et al. · Journal of the American Chemical Society · 1995 · 70 citations

Natural Sciences, Medicinal Chemistry, Pharmacology +6

Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers

Timothy A. Blizzard, Frank DiNinno, Jerry D. Morgan et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 60 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

In Vitro Bioactivation of Dihydrobenzoxathiin Selective Estrogen Receptor Modulators by Cytochrome P450 3A4 in Human Liver Microsomes: Formation of Reactive Iminium and Quinone Type Metabolites

Zhoupeng Zhang, Qing Chen, Ying Li et al. · Chemical Research in Toxicology · 2005 · 59 citations

Medicine, Biochemistry, Pharmacology +16

1–5 of 26